^
Association details:
Biomarker:PTCH1 mutation
Cancer:Colorectal Cancer
Regimen:FOLFOX (5-fluorouracil + leucovorin calcium + oxaliplatin)
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: D – Preclinical
Source:
Title:

Role of PTCH1 C-terminal domain mutations in colorectal cancer

Published date:
05/28/2021
Excerpt:
Homozygous PTCH1 CTD indels between S1203 and R1308 were generated in SW620 cells by CRISPR/Cas9...mutant clones showed enhanced sensitivity to FOLFOX , as determined by viability and PARP cleavage...These findings reveal the oncogenic role of mutations in the PTCH1 CTD present in a subset of CRC cases...